STATE STREET CORP - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 70 filers reported holding OVID THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,258,787
+26.5%
1,109,059
+8.0%
0.00%
Q2 2023$3,367,350
+580.7%
1,026,631
+435.4%
0.00%
Q1 2023$494,671
-30.6%
191,733
-50.0%
0.00%
Q4 2022$713,246
+102.1%
383,466
+100.0%
0.00%
Q3 2022$353,000
-14.3%
191,7330.0%0.00%
Q2 2022$412,000
-31.6%
191,7330.0%0.00%
Q1 2022$602,000
+29.5%
191,733
+32.4%
0.00%
Q4 2021$465,000
-4.5%
144,8490.0%0.00%
Q3 2021$487,000
-20.6%
144,849
-7.7%
0.00%
Q2 2021$613,000
-87.3%
156,849
-87.0%
0.00%
Q1 2021$4,842,000
+183.5%
1,204,365
+62.9%
0.00%
Q4 2020$1,708,000
-59.1%
739,440
+1.7%
0.00%
Q3 2020$4,174,000
-23.0%
727,232
-1.2%
0.00%
Q2 2020$5,424,000
+1528.8%
735,956
+291.6%
0.00%
Q1 2019$333,000
-19.0%
187,915
+10.7%
0.00%
Q4 2018$411,000
-60.5%
169,815
-7.6%
0.00%
Q3 2018$1,041,000
-5.2%
183,764
+30.6%
0.00%
Q2 2018$1,098,000
+47.0%
140,744
+33.1%
0.00%
Q1 2018$747,000
-0.1%
105,728
+39.9%
0.00%
Q4 2017$748,000
+21.4%
75,566
+5.0%
0.00%
Q3 2017$616,000
+18.5%
71,935
+45.0%
0.00%
Q2 2017$520,00049,6000.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
TLS Advisors LLC 1,319,679$4,32918.57%
Madison Avenue Partners, LP 3,307,605$10,848,9432.37%
CHI Advisors LLC 864,822$2,836,6160.86%
Rubric Capital Management LP 5,445,910$17,862,5850.76%
BVF INC/IL 6,851,051$22,471,4470.63%
EcoR1 Capital, LLC 6,117,400$20,065,0720.49%
Artal Group S.A. 2,500,000$8,2000.25%
Tejara Capital Ltd 112,591$369,2980.18%
DCF Advisers, LLC 64,764$212,4260.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 801,152$2,627,7790.06%
View complete list of OVID THERAPEUTICS INC shareholders